Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).

Robin Park, Christine H. Chung, Tyler J. Kristoff et al.|Journal of Clinical Oncology|2023

Cited by 1